132 related articles for article (PubMed ID: 16216591)
1. Aspirin inhibits thrombin action on endothelial cells via up-regulation of aminopeptidase N/CD13 expression.
Kato M; Azuma H; Akaike M; Iuchi T; Aihara K; Ikeda Y; Fujimura M; Yoshida T; Yamaguchi H; Hashizume S; Matsumoto T
Atherosclerosis; 2005 Nov; 183(1):49-55. PubMed ID: 16216591
[TBL] [Abstract][Full Text] [Related]
2. Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo.
Yamashita M; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F
Int J Cancer; 2007 May; 120(10):2243-50. PubMed ID: 17266036
[TBL] [Abstract][Full Text] [Related]
3. Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells.
Mishima Y; Terui Y; Sugimura N; Matsumoto-Mishima Y; Rokudai A; Kuniyoshi R; Hatake K
Cancer Sci; 2007 Mar; 98(3):364-72. PubMed ID: 17270026
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells.
Terauchi M; Kajiyama H; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F
BMC Cancer; 2007 Jul; 7():140. PubMed ID: 17655775
[TBL] [Abstract][Full Text] [Related]
5. Possible contribution of aminopeptidase N (APN/CD13) to migration and invasion of human osteosarcoma cell lines.
Liang W; Gao B; Xu G; Weng D; Xie M; Qian Y
Int J Oncol; 2014 Dec; 45(6):2475-85. PubMed ID: 25340499
[TBL] [Abstract][Full Text] [Related]
6. CIP-13F, a novel aminopeptidase N (APN/CD13) inhibitor, inhibits Lewis lung carcinoma growth and metastasis in mice.
Pei KL; Yuan Y; Qin SH; Wang Y; Zhou L; Zhang HL; Qu XJ; Cui SX
Cancer Chemother Pharmacol; 2012 Apr; 69(4):1029-38. PubMed ID: 22186885
[TBL] [Abstract][Full Text] [Related]
7. Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.
Cui SX; Qu XJ; Gao ZH; Zhang YS; Zhang XF; Zhao CR; Xu WF; Li QB; Han JX
Cancer Lett; 2010 Jun; 292(2):153-62. PubMed ID: 20042271
[TBL] [Abstract][Full Text] [Related]
8. Leukemic cell-surface CD13/aminopeptidase N and resistance to apoptosis mediated by endothelial cells.
Mishima Y; Matsumoto-Mishima Y; Terui Y; Katsuyama M; Yamada M; Mori M; Ishizaka Y; Ikeda K; Watanabe J; Mizunuma N; Hayasawa H; Hatake K
J Natl Cancer Inst; 2002 Jul; 94(13):1020-8. PubMed ID: 12096087
[TBL] [Abstract][Full Text] [Related]
9. Regulation of aminopeptidase N (EC 3.4.11.2; APN; CD13) on the HL-60 cell line by TGF-beta(1).
Gabrilovac J; Breljak D; Cupić B
Int Immunopharmacol; 2008 May; 8(5):613-23. PubMed ID: 18387503
[TBL] [Abstract][Full Text] [Related]
10. Induction of aminopeptidase N/CD13 on human lymphocytes after adhesion to fibroblast-like synoviocytes, endothelial cells, epithelial cells, and monocytes/macrophages.
Riemann D; Kehlen A; Thiele K; Löhn M; Langner J
J Immunol; 1997 Apr; 158(7):3425-32. PubMed ID: 9120303
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta increases the expression of aminopeptidase N/CD13 mRNA and protein in monocytes and monocytic cell lines.
Kehlen A; Langner J; Riemann D
Adv Exp Med Biol; 2000; 477():49-56. PubMed ID: 10849730
[TBL] [Abstract][Full Text] [Related]
12. LYP, a bestatin dimethylaminoethyl ester, inhibited cancer angiogenesis both in vitro and in vivo.
Gao JJ; Xue X; Gao ZH; Cui SX; Cheng YN; Xu WF; Tang W; Qu XJ
Microvasc Res; 2011 Sep; 82(2):122-30. PubMed ID: 21664364
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice.
Aozuka Y; Koizumi K; Saitoh Y; Ueda Y; Sakurai H; Saiki I
Cancer Lett; 2004 Dec; 216(1):35-42. PubMed ID: 15500947
[TBL] [Abstract][Full Text] [Related]
14. Potential indirect anti-inflammatory effects of IL-4. Stimulation of human monocytes, macrophages, and endothelial cells by IL-4 increases aminopeptidase-N activity (CD13; EC 3.4.11.2).
van Hal PT; Hopstaken-Broos JP; Prins A; Favaloro EJ; Huijbens RJ; Hilvering C; Figdor CG; Hoogsteden HC
J Immunol; 1994 Sep; 153(6):2718-28. PubMed ID: 7915741
[TBL] [Abstract][Full Text] [Related]
15. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
Kehlen A; Lendeckel U; Dralle H; Langner J; Hoang-Vu C
Cancer Res; 2003 Dec; 63(23):8500-6. PubMed ID: 14679016
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD13/aminopeptidase N on human gingival fibroblasts and up-regulation upon stimulation with interleukin-4 and interleukin-13.
Kunii R; Nemoto E; Kanaya S; Tsubahara T; Shimauchi H
J Periodontal Res; 2005 Apr; 40(2):138-46. PubMed ID: 15733148
[TBL] [Abstract][Full Text] [Related]
17. Novel leucine ureido derivatives as inhibitors of aminopeptidase N (APN).
Ma C; Jin K; Cao J; Zhang L; Li X; Xu W
Bioorg Med Chem; 2013 Apr; 21(7):1621-7. PubMed ID: 23453219
[TBL] [Abstract][Full Text] [Related]
18. Paracrine regulation of fibroblast aminopeptidase N/CD13 expression by keratinocyte-releasable stratifin.
Lai A; Ghaffari A; Li Y; Ghahary A
J Cell Physiol; 2011 Dec; 226(12):3114-20. PubMed ID: 21302309
[TBL] [Abstract][Full Text] [Related]
19. CD13/APN transcription is regulated by the proto-oncogene c-Maf via an atypical response element.
Mahoney KM; Petrovic N; Schacke W; Shapiro LH
Gene; 2007 Nov; 403(1-2):178-87. PubMed ID: 17897790
[TBL] [Abstract][Full Text] [Related]
20. Stromal cell-mediated transcriptional regulation of the CD13/aminopeptidase N gene in leukemic cells.
Saito M; Kumagai M; Okazaki T; Nakazawa S; Shapiro LH; Look AT; Campana D
Leukemia; 1995 Sep; 9(9):1508-16. PubMed ID: 7658720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
